Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphate-Reference-Cited by-同舟云学术

Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphate

Published:2016-09-29 Issue:1 Volume:35 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Ignat Mihaela^ORCID,Akladios Cherif Youssef,Lindner Véronique,Khetchoumian Konstantin,Teletin Marius,Muttter Didier,Aprahamian Pierre Marc,Marescaux Jacques

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-016-0434-8.pdf

Reference26 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.

2. Gomaa AI, Waked I. Recent advances in multidisciplinary management of hepatocellular carcinoma. World J Hepatol. 2015;7:673–87.

3. Guler S, Cimen S, Molinari M. Advances in loco-regional palliation of unresectable cholangiocarcinomas. Ann Palliat Med. 2014;3:65–74.

4. Kelland LR. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer. 2004;40:827–36.

5. Heindryckx F, Colle I, Van Vlierberghe H. Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol. 2009;90:367–86.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape;Journal of Advanced Research;2023-12

2. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy;Seminars in Cancer Biology;2023-12

3. LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease;Experimental & Molecular Medicine;2023-07-03

4. Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy;Cancers;2023-02-15

5. New potential treatment for cardiovascular disease through modulation of hemoglobin oxygen binding curve: Myo-inositol trispyrophosphate (ITPP), from cancer to cardiovascular disease;Biomedicine & Pharmacotherapy;2022-10